Insider Transactions in Q2 2025 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2025
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
7,000
-6.73%
|
$28,000
$4.59 P/Share
|
|
Jun 05
2025
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
59,225
+25.02%
|
-
|
|
Jun 05
2025
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
59,225
+32.44%
|
-
|
|
Jun 05
2025
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
59,225
+36.27%
|
-
|
|
Jun 05
2025
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
59,225
+33.22%
|
-
|
|
Jun 05
2025
|
Tage Honore |
BUY
Grant, award, or other acquisition
|
Direct |
59,225
+32.42%
|
-
|
|
May 21
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.21%
|
$40,000
$4.4 P/Share
|
|
May 16
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+0.86%
|
$80,000
$4.22 P/Share
|